Michael was Chief Executive Officer at Obsidian Therapeutics, and Chief Executive Officer at Padlock Therapeutics. Michael Gilman joined Arrakis Therapeutics in 2016. Michael served as Chief Executive Officer and Chairman of the Board at Arrakis Therapeutics.
Michael Gilman is currently
Create your alert
to follow the career of Michael Gilman.
Michael Gilman has a Bachelor of Science in Life Science from Massachusetts Institute of Technology in 1976 and a PhD in Biochemistry from University of California, Berkeley in 1983.
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
Do you need to know more about Michael Gilman? More results.
Report an error
Update the org chart details of Michael Gilman.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.